$11.46
0.09% yesterday
Nasdaq, Nov 20, 10:00 pm CET
ISIN
JE00BYSS4X48
Symbol
NVCR

Novocure Ltd. Stock price

$11.46
-3.02 20.86% 1M
-6.74 37.03% 6M
-18.34 61.54% YTD
-5.40 32.03% 1Y
-63.84 84.78% 3Y
-120.90 91.34% 5Y
-10.58 48.00% 10Y
-6.82 37.31% 20Y
Nasdaq, Closing price Thu, Nov 20 2025
+0.01 0.09%

New AI Insights on Novocure Ltd. Insights AI Insights on Novocure Ltd.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.0b
Net debt
positive
Cash
$1.0b
Shares outstanding
112.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.0 | 1.9
EV/Sales
1.6 | 1.5
EV/FCF
negative
P/B
3.8
Financial Health
Equity Ratio
29.0%
Return on Equity
-46.8%
ROCE
-30.0%
ROIC
-184.6%
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$642.3m | $662.9m
EBITDA
$-162.1m | $-58.1m
EBIT
$-175.6m | $-176.8m
Net Income
$-177.7m | $-160.3m
Free Cash Flow
$-65.2m
Growth (TTM | estimate)
Revenue
11.2% | 9.5%
EBITDA
-11.0% | 63.1%
EBIT
-11.9% | -4.9%
Net Income
-18.6% | 5.0%
Free Cash Flow
16.7%
Margin (TTM | estimate)
Gross
75.6%
EBITDA
-25.2% | -8.8%
EBIT
-27.3%
Net
-27.7% | -24.2%
Free Cash Flow
-10.2%
More
EPS
$-1.6
FCF per Share
$-0.6
Short interest
8.1%
Employees
1k
Rev per Employee
$410.0k
Show more

Is Novocure Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Novocure Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Novocure Ltd. forecast:

10x Buy
71%
4x Hold
29%

Analyst Opinions

14 Analysts have issued a Novocure Ltd. forecast:

Buy
71%
Hold
29%

Financial data from Novocure Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
642 642
11% 11%
100%
- Direct Costs 157 157
15% 15%
24%
485 485
10% 10%
76%
- Selling and Administrative Expenses 444 444
15% 15%
69%
- Research and Development Expense 215 215
1% 1%
33%
-162 -162
11% 11%
-25%
- Depreciation and Amortization 14 14
25% 25%
2%
EBIT (Operating Income) EBIT -176 -176
12% 12%
-27%
Net Profit -178 -178
19% 19%
-28%

In millions USD.

Don't miss a Thing! We will send you all news about Novocure Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novocure Ltd. Stock News

Positive
The Motley Fool
8 days ago
A biotech upstart and a life sciences giant could be compelling additions to an investor's portfolio. NovoCure is a high-risk but potentially high-reward bet on industry-changing technology.
Neutral
Business Wire
8 days ago
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025. Ashley Cordova, Chief Executive Officer, will present on behalf of the company at 2:00 p.m. GMT (9:00 a.m. ET). Ms. Cordova will be joined by Christoph Brackmann, Chief Financial Officer, for one-on-...
Neutral
Seeking Alpha
21 days ago
NovoCure Limited ( NVCR ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Ingrid Goldberg - VP of Investor Relations William Doyle - Executive Chairman Ashley Cordova - CEO & Director Christoph Brackmann - Chief Financial Officer Frank Leonard - President Conference Call Participants Jason Bednar - Piper Sandler & Co., Research Division Kevin Joaquin - Evercore ISI Insti...
More Novocure Ltd. News

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Head office Jersey
CEO Ms. Cordova
Employees 1,488
Founded 2000
Website www.novocure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today